Home
Conditions
Leukemia, Myelogenous, Chronic, BCR-ABL Positive

Clinical trial condition

Leukemia, Myelogenous, Chronic, BCR-ABL Positive

Explore clinical trials studying Leukemia, Myelogenous, Chronic, BCR-ABL Positive. Study availability and eligibility vary by location and protocol.

601 public trials 70 recruiting studies

Refine in advanced search Browse all conditions

Leukemia, Myelogenous, Chronic, BCR-ABL Positive trial results

Completed

Non-interventional Treatment Patterns Study in Chronic Phase Chronic Myelogenous Leukemia (CP-CML)

NCT01394666

Conditions: Bone Marrow Diseases, Chronic Disease, Chronic Myeloid Leukemia, +11 more
Locations: Not specified

View Trial Details

Completed

Safety Study of Human Myeloid Progenitor Cells (CLT-008) After Chemotherapy for Leukemia

NCT01297543

Conditions: Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, Anemia, +25 more
Locations: Moores UCSD Cancer Center La Jolla, California, United States

University of California San Francisco Medical Center San Francisco, California, United States

Stanford Hospital and Clinics Stanford, California, United States

Loyola University Medical Center, Cardinal Bernardin Cancer Center Maywood, Illinois, United States

View Trial Details

Completed

Study Evaluating SKI-606 (Bosutinib) In Japanese Subjects With Philadelphia Chromosome Positive Leukemias

NCT00811070

Conditions: Bone Marrow Diseases, Chronic Disease, Chronic Myelogenous Leukemia, +11 more
Locations: Kumamoto University Hospital Kumamoto, Japan

Tohoku University Hospital Sendai, Miyagi, Japan

National Cancer Center Hospital Chuo-ku, Tokyo, Japan

Toyohashi Municipal Hospital Aichi, Japan

View all 23 locations

View Trial Details

Completed

A Study of Withdrawal of Immunosuppression and Donor Lymphocyte Infusions Following Allogeneic Transplant for Pediatric Hematologic Malignancies

NCT01036009

Conditions: Acute Leukemia, Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, +30 more
Locations: University of California San Francisco, California, United States

All Children's Hospital St. Petersburg, Florida, United States

View Trial Details

Completed

High-Dose Gleevec Alone or in Combination With Peg-Intron and GM-CSF in Early Phase Chronic Myelogenous Leukemia (CML)

NCT00050531

Conditions: Bone Marrow Diseases, Chronic Disease, Disease Attributes, +12 more
Locations: University of Texas MD Anderson Cancer Center Houston, Texas, United States

View Trial Details

Completed

Late Chronic Phase Chronic Myelogenous Leukemia

NCT01092741

Conditions: Bone Marrow Diseases, Chronic Disease, Disease Attributes, +10 more
Locations: The University Of MD Anderson Cancer Center Houston, Texas, United States

View Trial Details

Completed

Effect of Imatinib Mesylate and the Pharmacokinetics of Acetaminophen/Paracetamol in Patients With Newly Diagnosed, Previously Untreated Chronic Myeloid Leukemia in Chronic Phase (CML-CP)

NCT00428909

Conditions: Bone Marrow Diseases, Chromosome Aberrations, Chronic Disease, +14 more
Locations: Novartis Investigative Site Seoul, South Korea

View Trial Details

Completed

Nilotinib Pre and Post Allogeneic Stem Cell Transplantation

NCT00750659

Conditions: Acute Lymphoblastic Leukemia, Bone Marrow Diseases, Chronic Disease, +19 more
Locations: Chaim Sheba Medical Center Tel Litwinsky, Israel

View Trial Details

Completed

Belinostat and Bortezomib in Treating Patients With Relapsed or Refractory Acute Leukemia or Myelodysplastic Syndrome

NCT01075425

Conditions: Acute Lymphocytic Leukemia, Acute Myeloid Leukemia, Bone Marrow Diseases, +22 more
Locations: M D Anderson Cancer Center Houston, Texas, United States

Virginia Commonwealth University Richmond, Virginia, United States

View Trial Details

Completed

Metabolic Outcomes in Patients Receiving Tyrosine Kinase Inhibitor (TKI) Therapy With Dasatinib or Nilotinib

NCT02733445

Conditions: Bone Marrow Diseases, Chronic Disease, Chronic Myeloid Leukemia (CML), +11 more
Locations: Not specified

View Trial Details

Leukemia, Myelogenous, Chronic, BCR-ABL Positive

Leukemia, Myelogenous, Chronic, BCR-ABL Positive trial results

Related conditions